Prescreening versus empirical immunization for hepatitis A in patients with chronic liver disease: A prospective cost analysis

American Journal of Gastroenterology

Volumn 97, Issue 7, 2002, Pages 1792-1795

  Duncan, Marten ^a   Hirota, William K ^a   Tsuchida, Amy ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE;

ACTIVE IMMUNIZATION; ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; FEMALE; HEALTH CARE COST; HEPATITIS A; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING TEST; SEROPREVALENCE; SOCIOECONOMICS;

EID: 0036314326     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04200-4     Document Type: Article

References (20)

1. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices
2. Seroepidemiology of hepatitis A in the United States
3. Hepatitis A vaccine
4. The cost of a foodborne outbreak of hepatitis A in Denver, Colorado
5. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?
6. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C
7. Public health control of hepatitis A: Memorandum from a WHO meeting
8. Cost-effective analysis of hepatitis A prevention in Ireland
9. Cost-effectiveness analysis of hepatitis A vaccination strategies for adults
10. Cost-effectiveness of hepatitis A vaccination in healthcare workers
11. An economic evaluation of hepatitis A vaccination in Dutch military personnel
12. Cost effectiveness of alternative hepatitis A immunization strategies
13. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines
14. Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic
15. Serious hepatitis A: An analysis of patients hospitalized during an urban epidemic in the United States
16. Are HCV-infected individuals candidates for hepatitis A vaccine?
17. Immunogenicity of hepatitis A vaccine in decompensated liver disease
18. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C
19. Prevalence of immunity to hepatitis A and B in patients undergoing orthotopic liver transplantation
20. Preventing acute liver disease in patients with chronic liver disease